AnyCoat® - From Nature, Beside You

AnyCoat®: Advanced Cellulose Ethers for Pharma and Nutraceutical Excellence
Manufactured by LOTTE Fine Chemical

Product Overview
AnyCoat® represents a premium range of cellulose ether derivatives—Hypromellose (HPMC) and Hypromellose Phthalate (HPMCP)—developed specifically for the pharmaceutical and nutraceutical industries. Trusted by industry leaders worldwide, AnyCoat® ensures versatility, quality, and global compliance, making it ideal for a range of applications.

Why Choose AnyCoat®?

  • Unmatched Quality: Fully compliant with USP/NF, EP, JP, and KP standards, with additional certifications like Kosher, ISO, DMF by the US FDA, and COS by EDQM.
  • Global Trust: Recognized and relied upon by pharmaceutical companies across the globe.
Solicitud de muestras Información regulatoria

Literatura del producto

Folleto del producto

Applications of AnyCoat®

  1. Tablet Coating
    Provides a clear, robust film with high tensile strength for reliable tablet coating.

  2. Controlled Release Matrix
    Acts as a hydrophilic matrix, allowing precise control over drug release.

  3. Viscosity Modification
    Enhances formulation viscosity, offering flexible application options across various products.

  4. Delayed-Release Coating
    Protects active pharmaceutical ingredients (APIs) from gastric acids, ensuring targeted release in the intestines.

AnyCoat® Product Range

  • AnyCoat-C (Hypromellose HPMC)
    Available in a wide range of viscosity levels (3 to 100,000 mPa·s), AnyCoat-C meets the needs of coating, matrix formulation, viscosity modification, and delayed release.

  • AnyCoat-P (Hypromellose Phthalate HPMCP)
    Designed for enteric coatings, AnyCoat-P provides essential protection to APIs from gastric acid, minimizing potential side effects in the stomach.

Plataforma de soluciones

Colorcon puede ayudarlo a reducir el tiempo en su proyecto al proporcionar la solución adecuada a través de la selección de excipientes y guía del proceso.

Productividad

Bajar el costo total y reducir el tiempo de lanzamiento al mercado

Diseño de disolución

Gestión del ciclo de vida de producto mediante un portfolio para perfiles de liberación modificada y extendida.

Cumplimiento del paciente

Reducir los errores en la medicación y mejorar la adhesión del paciente al tratamiento

Estabilidad

Performance del producto final estable y consistente

Autenticación de producto

Seguimiento y localización